Singapore's Lucence launches the first-ever alternative, early-detection lung cancer test in Hong Kong

Lucence, a Singaporean precision oncology company, and Hong Kong Precision Oncology Society (HKPOS) are embarking i...

April 10, 2025 | Thursday | News
China’s medtech takeover to reshape global healthcare sector

The global medtech landscape is undergoing a seismic shift, largely driven by the meteoric rise of Chinese companies. Fo...

April 9, 2025 | Wednesday | News
BioDuro opens new R&D and manufacturing campus in China to support biopharma sector

BioDuro is expanding its global contract research, development and manufacturing organisation (CRDMO) network with the o...

April 8, 2025 | Tuesday | News
Hong Kong develops nasal spray H5N1 avian influenza vaccine

The State Key Laboratory for Emerging Infectious Diseases at the University of Hong Kong (HKU) and the InnoHK Centre for...

April 4, 2025 | Friday | News
India's Morepen secures approval of anti-allergy API Loratadine for export to China

India-based Morepen Laboratories, a global leader in Active Pharmaceutical Ingredient (API) manufacturing, has received ...

April 1, 2025 | Tuesday | News
Peijia Medical collaborates with dsm-firmenich to create groundbreaking innovative medical device products

Peijia Medical Technology (Suzhou) Co. recently held a strategic innovation cooperation signing ceremony and a press con...

April 2, 2025 | Wednesday | News
Asia’s first bladder cancer organoid biobank pioneering new era in precision medicine

The Chinese University of Hong Kong’s (CUHK) Faculty of Medicine (CU Medicine) has created the first Asian populat...

March 28, 2025 | Friday | News
Merck inks $2 B agreement with Hengrui Pharma for cardiovascular drug

Merck, known as MSD outside of the United States and Canada, and Jiangsu Hengrui Pharmaceuticals Co., a global pharmaceu...

March 27, 2025 | Thursday | News
China's Bio-Thera inks biosimilar deal with India-based Dr. Reddy’s for Southeast Asia region

Bio-Thera Solutions, a China-based biopharmaceutical company developing a pipeline of innovative therapies and biosimila...

March 26, 2025 | Wednesday | News
United Laboratories and Novo Nordisk ink $2 B deal for treatment of obesity, diabetes and others

China based The United Laboratories International Holdings Limited (TUL) and Danish pharmaceutical company Novo Nordisk ...

March 25, 2025 | Tuesday | News
AstraZeneca announces investment of $2.5 B to establish sixth global strategic R&D centre in China

British pharmaceutical company AstraZeneca has announced an investment of $2.5 billion in Beijing to establish its sixth...

March 24, 2025 | Monday | News
BenQ Medical Technology and Brain Navi align partnership to advance neurosurgical robotics in China

Taiwan-based startup Brain Navi Biotechnology, a leading innovator in neurosurgical robotics, has announced a strategic ...

March 20, 2025 | Thursday | News
PolyU plans to establish Hong Kong’s third medical school

The Hong Kong Polytechnic University (PolyU) has submitted a proposal to the Hong Kong Special Administrative Region (HK...

March 21, 2025 | Friday | News
Harbour BioMed launches Élancé Therapeutics to advance next-gen obesity therapies

China & US based Harbour BioMed, a global biopharmaceutical company committed to the discovery, development and...

March 17, 2025 | Monday | News
Teva enhances pharma distribution system in China

Teva Hong Kong has announced a strategic partnership with Kerry Pharma, the subsidiary of Kerry Logistics Network (KLN)....

March 14, 2025 | Friday | News
Insilico Medicine secures $110 M Series E financing to advance AI-driven drug discovery innovation

Insilico Medicine, a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, has successfu...

March 13, 2025 | Thursday | News
WuXi XDC and AbTis announce strategic partnership to advance next-generation ADCs

WuXi XDC Cayman Inc., a leading global CRDMO (Contract Research, Development, and Manufacturing Organization) specialisi...

March 11, 2025 | Tuesday | News
Report reveals high RSV-associated hospitalisation costs in Hong Kong & Singapore

A newly released white paper, based on research conducted independently by IQVIA, a global healthcare consultancy, ...

March 11, 2025 | Tuesday | News

Podcast

Survey Box

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls